- Aptyx has appointed David Price as Chief Executive Officer, effective immediately, following his tenure as Chief Financial Officer.
- The medical device CDMO said Price will focus on accelerating growth, strengthening customer partnerships, advancing operational excellence, and developing leadership capabilities.
Aptyx, a medical device CDMO, has appointed David Price as Chief Executive Officer, effective immediately. Price joined the company last year as Chief Financial Officer, where Aptyx said he helped strengthen execution, sharpen strategic priorities, and position the organization for its next phase of growth.
According to the company, Price brings experience in financial management, operations, commercial strategy, and business leadership. In his new role, he will focus on accelerating growth, deepening customer partnerships, advancing operational excellence, developing leadership capabilities, and strengthening Aptyx’s position as a contract manufacturing partner for medical device companies worldwide.
“David has earned the confidence of the Board through his leadership, business acumen, and clear commitment to our customers, employees, and growth strategy. He is the right leader to build on Aptyx’s strong foundation and accelerate the Company’s continued growth.”
John Pless, Co-Managing Partner of TruArc
Price succeeds to the CEO position after serving as CFO since joining the company last year. He said Aptyx operates in a dynamic medical device market and is well positioned to deliver innovative solutions through its technical capabilities, customer-focused culture, and commitment to quality standards.
